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Mediastinal massesAbstract Purpose: The purpose of this study is to evaluate the role of measurement of ADC value
in the differentiation between benign and malignant mediastinal lesions.
Patients and methods: 42 patients with 52 mediastinal lesions were included in this study. They
underwent diffusion weighted MRI with b values of 1000 and 0 s/mm2. ADC value measurement
and histopathological diagnosis were done for each lesion. Correlation between ADC value and
histopathology was done through statistical analysis.
Results: 32 lesions were malignant and 20 lesions were benign. The mean ADC value for the malig-
nant lesions was signiﬁcantly lower than the mean ADC value for benign lesions (P value <0.001).
The mean ADC value for malignant lesions was 0.91 ± 0.23  103 mm2/s while for the benign
lesions it was 1.80 ± 0.55  103 mm2/s. The cutoff point of the ADC value differentiating malig-
nant from benign mediastinal lesions was 1.15  103 mm2/s with sensitivity of 95%, speciﬁcity of
93.8%, positive predictive value of 90.5%, and negative predictive value of 96.8% and accuracy of
94.4%.
Conclusion: Diffusion weighted MRI and measurement of ADC value are very helpful in the dif-
ferentiation between benign and malignant mediastinal lesions.
 2015 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier
B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Mediastinal tumors represent wide diversity of disease states.
Although more than two thirds of mediastinal tumors are
120 A. Nasr et al.benign, masses in the anterior compartment are more likely to
be malignant (1,2). In the study by Davis et al. (3) of 400
patients with mediastinal masses, malignancy was seen in
59%, 29%, and 16% respectively of anterior, middle and pos-
terior mediastinal masses. Differentiation of malignant medi-
astinal tumors from benign lesions is essential for treatment
planning as well as for prediction of prognosis. Despite being
the most common modality used for imaging the mediastinum,
computed tomography (CT) cannot be used to reliably differ-
entiate benign from malignant lesions (4). With the advent of
the echo-planar magnetic resonance imaging (MRI) technique,
diffusion weighted-magnetic resonance imaging (DW-MRI) of
the abdomen and thoracic cavity has become possible with fast
imaging time that minimizes the effect of gross physiological
motion from respiration and cardiac movement (5). There is
growing interest in the application of diffusion weighted imag-
ing (DWI) in the evaluation of patients with cancer. The ADC
is inversely correlated with tissue cellularity. The motion of
water molecules is more restricted in tissues with a high cellularFig. 1 Non-Hodgkin lymphoma in 38-years-old male patient. (a
mediastinum exerting isointense signal. (b) On axial diffusion weighted
intensity lesion. (c) ADC map was reconstructed showing the mass h
value measuring 0.94  103 mm2/s. (d) CT scan of the chest without
lesion (CT guided core biopsy from the lesion).density associated with numerous intact cell membranes. The
ADC value is estimated to be lower in viable tumor tissue with
densely packed diffusion-hindering obstacles than in tissue
with less densely packed obstacles such as tumor necrosis
and benign tissue (6,7). The purpose of our study is to evaluate
the role of DWI and ADC value measurement in the differen-
tiation between benign and malignant mediastinal tumors.2. Patients and methods
2.1. Patients
42 patients with 52 mediastinal lesions were included in this
study. All the patients had CT chest showing mediastinal mass
and were referred from thoracic surgery outpatient clinic in
chest disease hospital, Kuwait, to radiology department to
do MRI before surgery or biopsy. Lesions containing large
amount of necrosis or calciﬁcation were excluded. Institutional) Axial T1 WI shows well-deﬁned mass lesion in the anterior
imaging with b value 1000 s/mm2 the mass appears as bright signal
as low signal intensity. The ROI was selected revealing low ADC
contrast, bone window showing the biopsy gun needle within the
Fig. 2 Schwannoma in 32-years-old female patient. (a) CT chest sagittal reformate mediastinal window shows large well-deﬁned oval
shaped mass lesion in superior posterior mediastinum. (b) Axial T2 WI FSE shows the mass projecting to the right side exerting
hyperintense signal. (c) On axial diffusion weighted imaging with b value of 1000 s/mm2 the mass has homogeneous hyperintense signal.
(d) ADC map was reconstructed showing hypointense signal of the mass and ADC value of the lesion was high measuring
1.81  103 mm2/s.
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from the patients were obtained.
2.2. MRI protocol
All MR studies were performed with a 1.5-T imager (Signa
Twinspeed HD; GE Healthcare, Waukesha, Wis) using a
phased-array body coil (Eight-Channel Body Array Coil; GE
Healthcare). Patients were imaged in the supine position. Prior
to diffusion weighted MRI, axial T1-weighted images and
coronal T2-weighted images with and without fat saturation
were obtained from each patient. Diffusion weighted MRI
was performed in the axial plane on the basis of T1- andTable 1 Shows comparison between mean ADC value of benign an
Pathology Number Mean AD
Benign lesions 20 1.80 ± 0
Malignant lesions 32 0.91 ± 0T2-weighted images. It was obtained during quiet breathing
with a motion-probing gradient (MPG) of b values of
1000 and 0 s/mm2 in all x, y, and z directions, using the follow-
ing parameters: spin-echo-based echo-planar imaging; 4100–
5100/49.8; receiver bandwidth 250 kHz; section thickness,
3 mm (gapless); ﬁeld of view 40–48 cm; echo space 396–420 s;
echo train length 96–128; and real spatial resolution in the
phase-encoding direction 2.08–2.50 mm. Apparent diffusion
coefﬁcient (ADC) maps were reconstructed in all cases by
using a software on the basis of the images obtained with a
b factor of 1000 s/mm2 and 0 s/mm2. ADC was calculated on
these maps by drawing elliptical regions of interest (ROI).
We used the same method of Gumustas et al. (8). The size ofd malignant mediastinal masses.
C value T test P value
.55  103 mm2/s 7.95 <0.001
.23  103 mm2/s
Table 2 Shows number and mean ADC value of different benign and malignant mediastinal lesions.
Pathology Number % of total (%) Mean ADC value
Lymphoma 15 28.8 0.96 ± 0.16  103 mm2/s
Small carcinoma 4 7.8 0.70 ± 0.23  103 mm2/s
Invasive thymoma 5 9.6 0.95 ± 0.17  103 mm2/s
Metastases 6 11.5 0.74 ± 0.29  103 mm2/s
Carcinoid 2 3.8 1.30 ± 0.0  103 mm2/s
Sarcoidosis 7 13.4 1.61 ± 0.41  103 mm2/s
Thymoma 4 7.8 1.35 ± 0.32  103 mm2/s
Schwannoma 4 7.8 1.81 ± 0.51  103 mm2/s
Neuroﬁbroma 3 5.7 1.76 ± 0.0  103 mm2/s
Thymic hyperplasia 2 3.8 2.1 ± 0.0  103 mm2/s
Total 52 100 1.25 ± 0.58  103 mm2/s
Table 3 Shows sensitivity and speciﬁcity of the ADC values used in the differentiation between malignant and benign mediastinal
mass.
Cutoﬀ value Sensitivity Speciﬁcity True+ True – PPV NPV kappa P
1.15  103 mm2/s 95% 93.8% 19 30 90.5% 96.8% 0.87 0.0001
1.0
ROC Curve
122 A. Nasr et al.the ROI was kept as large as possible covering at least two
thirds of the lesion yet avoiding interference from surrounding
lung tissue, major blood vessels and necrotic parts. This proce-
dure was done three times and the average of these measure-
ments was recorded as the ﬁnal mean ADC value. The ﬁnal
diagnosis was made by biopsy with histopathological examina-
tion. The biopsy was CT guided core biopsy in 28 patients,
bronchoscopic in 8 and open surgery in 6 patients.
2.3. Statistical analysis
Data analysis was done using SPSS software version 17.0. The
mean ADC value was calculated for benign and malignant
lesions. Student T test was used to compare between the
ADC value of both groups. A receiver operating curveFig. 3 Box and whisker plot of ADC value of the mediastinal
tumor shows signiﬁcant difference between the mean ADC value
of the benign and malignant lesions.(ROC) was used to detect the cutoff value to differentiate
malignant from benign mediastinal lesions with calculation
of sensitivity, speciﬁcity, accuracy, positive predictive value
(PPV), and negative predictive value (NPV).
3. Results
The mediastinal lesions were 32 malignant and 20 benign
lesions. Multiple lesions were seen in 9 patients. Multiple medi-












Diagonal segments are produced by ties.
Fig. 4 ROC curve shows the cutoff point ADC value for
differentiation between benign and malignant mediastinal lesions
is 1.15  103 mm2/s with sensitivity 95% and speciﬁcity 93.8%.
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cer, the primary lesion was associated with enlarged metastatic
lymph node. The mean ADC value for the malignant lesions
(Fig. 1) was 0.91 ± 0.23  103 mm2/s while the mean ADC
value for the benign lesions (Fig. 2) was 1.80
± 0.55  103 mm2/s. Comparison between the mean ADC
value of the benign and malignant mediastinal lesions was
highly signiﬁcant with P value <0.001 (Table 1). The malig-
nant tumors were lymphoma in 15 lesions, metastases in 6
lesions (lung cancer in 4 and breast cancer in 2), invasive
thymoma in 5 lesions and small cell lung carcinoma in 4 lesions
and carcinoid in 2 lesions. The benign lesions were sarcoid
lymphadenopathy in 7 lesions, thymoma in 4 lesions,
schwannoma in 4 lesions, neuroﬁbroma in 3 lesions and
thymic hyperplasia in 2 lesions. The number and mean ADC
value of different histopathological types of the benign and
malignant mediastinal lesions are shown in Table 2. There
was overlap between the mean ADC values of thymomas
(1.35  103 mm2/s) and that of carcinoid tumorsFig. 5 Thymoma AB in 39-years-old female patient. (a) Axial T
mediastinal mass lesion exerting isointense signal. (b) Coronal T2 FSE
(c) On Axial diffusion weighted imaging using b value 1000 s/mm2 the
mass shows hypointense signal with low ADC value measuring 1.13 (1.30  103 mm2/s). There was no signiﬁcant difference in
the mean ADC value between the different malignant lesions.
The receiver operator curve (ROC) analysis showed that the
cutoff point of the ADC value differentiating malignant medi-
astinal tumors from benign mediastinal lesions was
1.15  103 mm2/s with sensitivity of 95%, speciﬁcity of
93.8%, positive predictive value of 90.5%, negative predictive
value of 96.8% and accuracy of 94.4% (Table 3). The area
under curve was 0.98 (95%CI, 0.96–1.01). The lowest ADC
value of benign lesion was 1.13  103 mm2/s which is slightly
lower than the cutoff point and it was seen in patient with thy-
moma (WHO classiﬁcation type AB). The highest ADC value
in malignant lesions was 1.3  103 mm2/s which is slightly
above the cutoff point and it was seen in patient with a carci-
noid tumor. The lesions were more common in the anterior
mediastinum. They were located in the anterior mediastinum
in 30 lesions (57.7%), middle mediastinum in 12 lesions
(23%) and posterior mediastinum in 10 (19.3%) lesions. The
size of the lesions ranged from 2.2 cm to 8 cm with average size1 WI FSE shows well-deﬁned right paracardiac ovoid shaped
without fat saturation shows slight hyperintense signal of the mass.
mass exerts bright hyperintense signal. (d) On ADC mapping the
103 mm2/s.
124 A. Nasr et al.of 3.41 cm. The size of the malignant lesions ranged from
2.8 cm to 6 cm while the size of the benign lesions ranged from
2.2 cm to 8 cm with average size of 3.92 cm. There was no sig-
niﬁcant difference between the size of malignant and benign
lesion (p value was 0.53).4. Discussion
Computed tomography cannot be used reliably to differentiate
malignant from benign lesions of the mediastinum despite
being the most common modality for imaging this region (8).
The introduction of diffusion-weighted MR imaging (DWI)
has enabled us to obtain additional information derived from
the microscopic motion of water protons. Quantitative tumor
assessment is possible by the calculation of ADC value, which
is related to the proportion of extracellular and intracellular
components (9). The results of several studies have demon-
strated that ADC values of malignant hepatic, renal, prostaticFig. 6 Mediastinal lymph nodes metastases in 58-years-old female
window shows enhanced soft tissue mass lesion reterocardiac in the pos
mass exerting hyperintense signal. (c) On axial diffusion weighted ima
signal. (d) On ADC mapping the mass has low signal intensity lesionand uterine cervical tumors were lower than those of benign
lesions or normal tissue (10).
In agreement with the results of Abdel Razek et al. (11) and
Gumustas et al. (8), the results of our study demonstrated that
the mean ADC value of malignant mediastinal lesions was sig-
niﬁcantly lower than the mean ADC value of benign mediasti-
nal lesions (Fig. 3). We did not ﬁnd signiﬁcant difference in the
mean ADC value between lymphoma and other malignant
tumors encountered in this study. This is concordant with
other results (8,11) and discordant with results of Sumi et al.
(12) who found signiﬁcant difference in the mean ADC value
between lymphoma and carcinoma.
In the present study analysis of the receiver operating
curve (Fig. 4) revealed that the cutoff ADC value for the
differentiation between malignant and benign mediastinal
lesions was 1.15  103 mm2/s. This is discordant with the
results of Abdel Razek et al. (11) and Gumustas et al. (8)
who reported higher cutoff ADC values of 1.56  103 mm2/s
and 1.39  103 mm2/s respectively for the discriminationpatient with cancer breast. (a) CT scan of the chest mediastinal
terior mediastinum. (b) Axial T2 WI with fat saturation shows the
ging using b value 1000 s/mm2 the mass exerts bright hyperintense
with very low ADC value measuring 0.43  103 mm2/s.
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other hand our result is concordant with that of Tondo et al.
(13) who reported cutoff ADC value of 1.25  103 mm2/s.
The sensitivity and speciﬁcity of our cutoff ADC value were
95% and 93.8% similar to 96% and 94% for Abdel Razek
et al. (11), compared to 95% and 87% for Gumustas et al.
(8) and 91% and 100% for Tondo et al. (13).
The highest ADC value for benign lesions was
3  103 mm2/s in thymic hyperplasia while the lowest ADC
value of benign lesions and a patient with type AB thymoma
was 1.13  103 mm2/s which is slightly lower than the cutoff
point (Fig. 5). WHO classiﬁcation of type AB thymoma is not
always benign and 25% of thymoma AB can be invasive at
diagnosis and it has the potential to show malignant behavior
(14). There are reports of thymoma AB that gives liver and
brain metastases (15,16).
The lowest ADC value for malignant lesion was
0.43  103 mm2/s in patient with mediastinal lymph node
metastasis (Fig. 6) while the highest ADC value of malignant
lesion was 1.30  103 mm2/s which was above the cutoff
point and it was in patient with typical carcinoid tumor. Bron-
chial carcinoids range from low grade typical carcinoid to
intermediate grade atypical carcinoid to high grade small cell
carcinoma. Typical carcinoids consist of uniform cells contain-
ing small nucleoli. Mitoses are less numerous or absent (17)
and this can explain the slightly higher ADC value of our case.
5. Conclusion
Diffusion weighted MRI and measurement of ADC value are
very helpful in the differentiation between benign and malig-
nant mediastinal lesions.
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